ClinicalTrials.gg
Drug

Zilucoplan clinical trials

studies test it
18
open now
4
in phase 3
10
first study started
2017

How each study uses zilucoplan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the zilucoplan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Oct 2023 · ZILBRYSQ · NDA 216834 (FDA, Drugs@FDA)
European Union
1 Dec 2023 · Zilbrysq · EMEA/H/C/005450 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zilucoplan
11
zilucoplan (RA101495)
7
RA101495
5

Studies by the year they started

18 studies that test it; most in 2017 (4)

Studies that test zilucoplan, by start year
YearStudies
20174
20193
20204
20221
20244
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
9
Phase 3
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 4

UCB Biopharma SRL (7) · Ra Pharmaceuticals (4) · Merit E. Cudkowicz, MD (2) · Ra Pharmaceuticals, Inc. (2) · University Hospital, Ghent (1) · Amgen (1) · Miriam Freimer (1)

Often tested with

Tested in the same studies.

AZD3241 (1) · CNM-Au8 (1) · Pridopidine (1) · SLS-005 (1) · Fosigotifator sodium tromethamine (1) · Fosigotifator (1) · Evetifator (1) · NUZ-001 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 3 in phase 3

Studies that test zilucoplan, phase 3 first.

Studies

Open first, then newest update. How each study uses zilucoplan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call zilucoplan · ClinicalTrials.gg INT001712

  • MeSH (NLM) C000719268zilucoplanConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) YG391PK0CCZILUCOPLANConfirmed FDA, NLM, Wikidata
  • Wikidata Q107340140zilucoplanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C147518ZilucoplanOne source FDA
  • DrugBank DB15636One source Wikidata

Also registered as zilucoplan sodium (UNII 10R1YC115A).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.